1
Chapterw1w-wThewNursingwProcesswandwDrugwTherapy ___________________ 3
Chapterw2w-wPharmacologicwPrinciples ________________________________ 7
Chapterw3w-wLifespanwConsiderations ________________________________ 13
Chapterw4w-wCulturalwLegalwandwEthicalwConsiderations__________________ 19
Chapterw5w-wMedicationwErrorswPreventingwandwResponding ______________ 25
Chapterw6w-wPatientwEducationwandwDrugwTherapy _____________________ 29
Chapterw 7w -w Over-the-
Counterw Drugsw andw Herbalw andw Dietaryw Supplementsw 34w Chapterw8w-
GenewTherapywandwPharmacogenomics _____________________________ 38
w
Chapterw9w-wPhotowAtlaswofwDrugwAdministration _______________________ 42
Chapterw10w-wAnalgesicwDrugs _____________________________________ 50
Chapterw11w-wGeneralwandwLocalwAnesthetics _________________________ 57
Chapterw 12w -
w Centralw Nervousw Systemw Depressantsw andw Musclew Relaxantsw 61w Chapterw1
3w-wCentralwNervouswSystemwStimulantswandwRelatedwDrugs _____________ 66
Chapterw14w-wAntiepilepticwDrugs ___________________________________ 70
Chapterw15w-wAnti-ParkinsonwDrugs__________________________________ 75
Chapterw16w-wPsychotherapeuticwDrugs ______________________________ 80
Chapterw17w-wSubstancewUsewDisorder _______________________________ 87
Chapterw18w-wAdrenergicwDrugs _____________________________________ 92
Chapterw19w-wAdrenergic-BlockingwDrugs _____________________________ 97
Chapterw20w-wCholinergicwDrugs ____________________________________ 102
Chapterw21w-wCholinergic-BlockingwDrugs _____________________________ 107
Chapterw22w-wAntihypertensivewDrugs ________________________________ 112
Chapterw23w-wAntianginalwDrugs ____________________________________ 118
Chapterw24w-wHeartwFailurewDrugs __________________________________ 124
Chapterw25w-wAntidysrhythmicwDrugs ________________________________ 129
Chapterw26w-wCoagulationwModifierwDrugs ____________________________ 134
Chapterw27w-wAntilipemicwDrugs ____________________________________ 140
Chapterw28w-wDiureticwDrugs _______________________________________ 145
Chapterw29w-wFluidswandwElectrolytes ________________________________ 151
, 2
Chapterw30w-wPituitarywDrugs _______________________________________ 157
Chapterw31w-wThyroidwandwAntithyroidwDrugs __________________________ 161
Chapterw32w-wAntidiabeticwDrugs ____________________________________ 166
Chapterw33w-wAdrenalwDrugs _______________________________________ 174
Chapterw34w-wWomen’swHealthwDrugs ________________________________ 178
Chapterw35w-wMen’swHealthwDrugs __________________________________ 185
Chapterw 36w -
w Antihistaminesw Decongestantsw Antitussivesw andw Expectorantsw 189wChapterw3
7w-wRespiratorywDrugs ____________________________________________ 194
Chapterw38w-wAntibioticswPartw1 _____________________________________ 199
Chapterw39w-wAntibioticswPartw2 _____________________________________ 206
Chapterw40w-wAntiviralwDrugs _______________________________________ 211
Chapterw41w-wAntitubercularwDrugs __________________________________ 216
Chapterw42w-wAntifungalwDrugs _____________________________________ 221
Chapterw43w-wAntimalarialwAntiprotozoalwandwAnthelminticwDrugs __________ 226
Chapterw44w-wAnti-inflammatorywandwAntigoutwDrugs ____________________ 231
Chapterw 45w -
w Antineoplasticw Drugsw Partw 1w Cancerw Overvieww andw Cellw Cyclew 236wChapterw4
6w-wAntineoplasticwDrugswPartw2wCellwCyclewNonspecificwandwMisc.
Drugs _________________________________________________________ 242
Chapterw47w-wBiologicwResponse–ModifyingwandwAntirheumaticwDrugs ______ 247
Chapterw48w-wImmunosuppressantwDrugs _____________________________ 252
Chapterw49w-wImmunizingwDrugs ____________________________________ 257
Chapterw50w-wAcid-ControllingwDrugs ________________________________ 262
Chapterw51w-wBowelwDisorderwDrugs _________________________________ 268
Chapterw52w-wAntiemeticwandwAntinauseawDrugs _______________________ 275
Chapterw53w-wVitaminswandwMinerals ________________________________ 280
Chapterw54w-wAnemiawDrugs _______________________________________ 286
Chapterw55w-wNutritionalwSupplements _______________________________ 292
Chapterw56w-wDrugs ______________________________________________ 296
Chapterw57w-wOphthalmicwDrugs ____________________________________ 302
Chapterw58w-wOticwDrugs __________________________________________ 307
,PharmacologywandwthewNursingwProcessw9thwEditionw9780323529
495
Chapterw01:wThewNursingwProcesswandwDrugwTherapy
Lilley: PharmacologywandwthewNursingwProcess, 9th
Edition
MULTIPLEwCHOICE
1. Thewnursewiswdevelopingwawhumanwneedswstatementwforwawpatientwwhowhaswawnewwdia
gnosiswofwheartwfailure.wIdentificationwofwhumanwneedswstatementswoccurwwithwwhichw
ofwthesewactivities?
a. Collectionwofwpatientwdata
b. Administeringwinterventions
c. Decidingwonwpatientwoutcomes
d. Documentingwthewpatient’swbehavior
ANS:w A
Identificationwofwhumanwneedswoccurswwithwthewcollectionwofwpatientwdata.
DIF:
CognitivewLevel:wUnderstandingw(Comprehensio
n)wTOP:w NursingwProcess:wHumanwNeedswStatement
MSC:w NCLEX:wSafewandwEffectivewCarewEnvironment:wManagementwofwCare
2. Thewpatientwiswtowreceiveworalwguaifenesinw(Mucinex)wtwicewawday.wToday,wthewnu
rsewwaswbusywandwgavewthewmedicationw2whourswafterwthewscheduledwdosewwaswd
ue.wWhatwtypewofwproblemwdoeswthiswrepresent?
a. “Rightwtime”
b. “Rightwdose”
c. “Rightwroute”
d. “Rightwmedication”
ANS:w A
“Rightwtime”wiswcorrectwbecausewthewmedicationwwaswgivenwmorewthanw30wminuteswaft
erwthewscheduledwdosewwaswdue.w“Dose”wiswincorrectwbecausewthewdosewiswnotwrelatedw
towthewtimewthewmedicationwadministrationwiswscheduled.w“Route”wiswincorrectwbecause
wthewroutewiswnotwaffected.w“Medication”wiswincorrectwbecausewthewmedicationwordered
wwillwnotwchange.
DIF:
CognitivewLevel:wApplyingw(Applicatio
n)wTOP:w NursingwProcess:wImplementation
MSC:w NCLEX:wSafewandwEffectivewCarewEnvironment:wSafetywandwInfectionwControl
3. Thewnursewhaswbeenwmonitoringwthewpatient’swprogresswonwawnewwdrugwregimenwsincew
thewfirstwdosewandwdocumentingwthewpatient’swtherapeuticwresponsewtowthewmedication.
wWhichwphasewofwthewnursingwprocesswdowthesewactionswillustrate?
a. Humanwneedswstatement
b. Planning
c. Implementation
d. Evaluation
ANS:w D
Monitoringwthewpatient’swprogress,wincludingwthewpatient’swresponsewtowthewmedication,
wiswpartwofwthewevaluationwphase.wPlanning,wimplementation,wandwhumanwneedswstateme
ntwarewnotwillustratedwbywthiswexample.
Chapterw1w- 3
wThewNursingwProcesswandwDrugwTherapy
, PharmacologywandwthewNursingwProcessw9thwEditionw9780323529
495
DIF: CognitivewLevel:wUnderstandingw(Comprehension)
TOP:w NursingwProcess:wEvaluation
MSC:w NCLEX:wSafewandwEffectivewCarewEnvironment:wManagementwofwCare
4. Thewnursewiswassignedwtowawpatientwwhowiswnewlywdiagnosedwwithwtypew1wdiabetesw
mellitus.wWhichwstatementwbestwillustrateswanwoutcomewcriterionwforwthiswpatient?
a. Thewpatientwwillwfollowwinstructions.
b. Thewpatientwwillwnotwexperiencewcomplications.
c. Thewpatientwwillwadherewtowthewnewwinsulinwtreatmentwregimen.
d. Thewpatientwwillwdemonstratewcorrectwbloodwglucosewtestingwtechnique.
ANS:w D
“Demonstratingwcorrectwbloodwglucosewtestingwtechnique”wiswawspecificwandwmeasurable
woutcomewcriterion.w“Followingwinstructions”wandw“notwexperiencingwcomplications”ware
wnotwspecificwcriteria.w“Adheringwtownewwregimen”wwouldwbewdifficultwtowmeasure.
DIF: CognitivewLevel:wApplyingw(Application)
TOP:w NursingwProcess:wPlanning
MSC:w NCLEX:wSafewandwEffectivewCarewEnvironment:wManagementwofwCare
5. Whichwactivitywbestwreflectswthewimplementationwphasewofwthewnursingwprocesswforwthe
wpatientwwhowiswnewlywdiagnosedwwithwhypertension?
a. Providingweducationwonwkeepingwawjournalwofwbloodwpressurewreadings
b. Settingwgoalswandwoutcomewcriteriawwithwthewpatient’swinput
c. Recordingwawdrugwhistorywregardingwover-the-counterwmedicationswusedwatwhome
d. Formulatingwhumanwneedswstatementswregardingwinsufficientwknowledgewrelate
dwtowthewnewwtreatmentwregimen
ANS:w A
Educationwiswanwinterventionwthatwoccurswduringwthewimplementationwphase.wSettingwg
oalswandwoutcomeswreflectswthewplanningwphase.wRecordingwawdrugwhistorywreflectswthe
wassessmentwphase.wFormulatingwhumanwneedswstatementswreflectswanalysiswofwdatawas
wpartwofwplanning.
DIF:
CognitivewLevel:wApplyingw(Applicatio
n)wTOP:w NursingwProcess:wImplementation
MSC:w NCLEX:wSafewandwEffectivewCarewEnvironment:wManagementwofwCare
6. Thewmedicationworderwreads,w“Givewondansetronw(Zofran)w4wmg,w30wminuteswbeforewb
eginningwchemotherapywtowpreventwnausea.”wThewnursewnoteswthatwthewroutewiswmissing
wfromwtheworder.wWhatwiswthewnurse’swbestwaction?
a. Givewthewmedicationwintravenouslywbecausewthewpatientwmightwvomit.
b. Givewthewmedicationworallywbecausewthewtabletswarewavailablewinw4-mgwdoses.
c. Contactwthewprescriberwtowclarifywthewroutewofwthewmedicationwordered.
d. Holdwthewmedicationwuntilwthewprescriberwreturnswtowmakewrounds.
ANS:w C
Awcompletewmedicationworderwincludeswthewroutewofwadministration.wIfwawmedicationwo
rderwdoeswnotwincludewthewroute,wthewnursewmustwaskwthewprescriberwtowclarifywit.wThe
wintravenouswandworalwrouteswarewnotwinterchangeable.wHoldingwthewmedicationwuntilwth
ewprescriberwreturnswwouldwmeanwthatwthewpatientwwouldwnotwreceivewawneededwmedica
tion.
DIF: CognitivewLevel:wApplyingw(Application)
Chapterw1w- 4
wThewNursingwProcesswandwDrugwTherapy
Chapterw1w-wThewNursingwProcesswandwDrugwTherapy ___________________ 3
Chapterw2w-wPharmacologicwPrinciples ________________________________ 7
Chapterw3w-wLifespanwConsiderations ________________________________ 13
Chapterw4w-wCulturalwLegalwandwEthicalwConsiderations__________________ 19
Chapterw5w-wMedicationwErrorswPreventingwandwResponding ______________ 25
Chapterw6w-wPatientwEducationwandwDrugwTherapy _____________________ 29
Chapterw 7w -w Over-the-
Counterw Drugsw andw Herbalw andw Dietaryw Supplementsw 34w Chapterw8w-
GenewTherapywandwPharmacogenomics _____________________________ 38
w
Chapterw9w-wPhotowAtlaswofwDrugwAdministration _______________________ 42
Chapterw10w-wAnalgesicwDrugs _____________________________________ 50
Chapterw11w-wGeneralwandwLocalwAnesthetics _________________________ 57
Chapterw 12w -
w Centralw Nervousw Systemw Depressantsw andw Musclew Relaxantsw 61w Chapterw1
3w-wCentralwNervouswSystemwStimulantswandwRelatedwDrugs _____________ 66
Chapterw14w-wAntiepilepticwDrugs ___________________________________ 70
Chapterw15w-wAnti-ParkinsonwDrugs__________________________________ 75
Chapterw16w-wPsychotherapeuticwDrugs ______________________________ 80
Chapterw17w-wSubstancewUsewDisorder _______________________________ 87
Chapterw18w-wAdrenergicwDrugs _____________________________________ 92
Chapterw19w-wAdrenergic-BlockingwDrugs _____________________________ 97
Chapterw20w-wCholinergicwDrugs ____________________________________ 102
Chapterw21w-wCholinergic-BlockingwDrugs _____________________________ 107
Chapterw22w-wAntihypertensivewDrugs ________________________________ 112
Chapterw23w-wAntianginalwDrugs ____________________________________ 118
Chapterw24w-wHeartwFailurewDrugs __________________________________ 124
Chapterw25w-wAntidysrhythmicwDrugs ________________________________ 129
Chapterw26w-wCoagulationwModifierwDrugs ____________________________ 134
Chapterw27w-wAntilipemicwDrugs ____________________________________ 140
Chapterw28w-wDiureticwDrugs _______________________________________ 145
Chapterw29w-wFluidswandwElectrolytes ________________________________ 151
, 2
Chapterw30w-wPituitarywDrugs _______________________________________ 157
Chapterw31w-wThyroidwandwAntithyroidwDrugs __________________________ 161
Chapterw32w-wAntidiabeticwDrugs ____________________________________ 166
Chapterw33w-wAdrenalwDrugs _______________________________________ 174
Chapterw34w-wWomen’swHealthwDrugs ________________________________ 178
Chapterw35w-wMen’swHealthwDrugs __________________________________ 185
Chapterw 36w -
w Antihistaminesw Decongestantsw Antitussivesw andw Expectorantsw 189wChapterw3
7w-wRespiratorywDrugs ____________________________________________ 194
Chapterw38w-wAntibioticswPartw1 _____________________________________ 199
Chapterw39w-wAntibioticswPartw2 _____________________________________ 206
Chapterw40w-wAntiviralwDrugs _______________________________________ 211
Chapterw41w-wAntitubercularwDrugs __________________________________ 216
Chapterw42w-wAntifungalwDrugs _____________________________________ 221
Chapterw43w-wAntimalarialwAntiprotozoalwandwAnthelminticwDrugs __________ 226
Chapterw44w-wAnti-inflammatorywandwAntigoutwDrugs ____________________ 231
Chapterw 45w -
w Antineoplasticw Drugsw Partw 1w Cancerw Overvieww andw Cellw Cyclew 236wChapterw4
6w-wAntineoplasticwDrugswPartw2wCellwCyclewNonspecificwandwMisc.
Drugs _________________________________________________________ 242
Chapterw47w-wBiologicwResponse–ModifyingwandwAntirheumaticwDrugs ______ 247
Chapterw48w-wImmunosuppressantwDrugs _____________________________ 252
Chapterw49w-wImmunizingwDrugs ____________________________________ 257
Chapterw50w-wAcid-ControllingwDrugs ________________________________ 262
Chapterw51w-wBowelwDisorderwDrugs _________________________________ 268
Chapterw52w-wAntiemeticwandwAntinauseawDrugs _______________________ 275
Chapterw53w-wVitaminswandwMinerals ________________________________ 280
Chapterw54w-wAnemiawDrugs _______________________________________ 286
Chapterw55w-wNutritionalwSupplements _______________________________ 292
Chapterw56w-wDrugs ______________________________________________ 296
Chapterw57w-wOphthalmicwDrugs ____________________________________ 302
Chapterw58w-wOticwDrugs __________________________________________ 307
,PharmacologywandwthewNursingwProcessw9thwEditionw9780323529
495
Chapterw01:wThewNursingwProcesswandwDrugwTherapy
Lilley: PharmacologywandwthewNursingwProcess, 9th
Edition
MULTIPLEwCHOICE
1. Thewnursewiswdevelopingwawhumanwneedswstatementwforwawpatientwwhowhaswawnewwdia
gnosiswofwheartwfailure.wIdentificationwofwhumanwneedswstatementswoccurwwithwwhichw
ofwthesewactivities?
a. Collectionwofwpatientwdata
b. Administeringwinterventions
c. Decidingwonwpatientwoutcomes
d. Documentingwthewpatient’swbehavior
ANS:w A
Identificationwofwhumanwneedswoccurswwithwthewcollectionwofwpatientwdata.
DIF:
CognitivewLevel:wUnderstandingw(Comprehensio
n)wTOP:w NursingwProcess:wHumanwNeedswStatement
MSC:w NCLEX:wSafewandwEffectivewCarewEnvironment:wManagementwofwCare
2. Thewpatientwiswtowreceiveworalwguaifenesinw(Mucinex)wtwicewawday.wToday,wthewnu
rsewwaswbusywandwgavewthewmedicationw2whourswafterwthewscheduledwdosewwaswd
ue.wWhatwtypewofwproblemwdoeswthiswrepresent?
a. “Rightwtime”
b. “Rightwdose”
c. “Rightwroute”
d. “Rightwmedication”
ANS:w A
“Rightwtime”wiswcorrectwbecausewthewmedicationwwaswgivenwmorewthanw30wminuteswaft
erwthewscheduledwdosewwaswdue.w“Dose”wiswincorrectwbecausewthewdosewiswnotwrelatedw
towthewtimewthewmedicationwadministrationwiswscheduled.w“Route”wiswincorrectwbecause
wthewroutewiswnotwaffected.w“Medication”wiswincorrectwbecausewthewmedicationwordered
wwillwnotwchange.
DIF:
CognitivewLevel:wApplyingw(Applicatio
n)wTOP:w NursingwProcess:wImplementation
MSC:w NCLEX:wSafewandwEffectivewCarewEnvironment:wSafetywandwInfectionwControl
3. Thewnursewhaswbeenwmonitoringwthewpatient’swprogresswonwawnewwdrugwregimenwsincew
thewfirstwdosewandwdocumentingwthewpatient’swtherapeuticwresponsewtowthewmedication.
wWhichwphasewofwthewnursingwprocesswdowthesewactionswillustrate?
a. Humanwneedswstatement
b. Planning
c. Implementation
d. Evaluation
ANS:w D
Monitoringwthewpatient’swprogress,wincludingwthewpatient’swresponsewtowthewmedication,
wiswpartwofwthewevaluationwphase.wPlanning,wimplementation,wandwhumanwneedswstateme
ntwarewnotwillustratedwbywthiswexample.
Chapterw1w- 3
wThewNursingwProcesswandwDrugwTherapy
, PharmacologywandwthewNursingwProcessw9thwEditionw9780323529
495
DIF: CognitivewLevel:wUnderstandingw(Comprehension)
TOP:w NursingwProcess:wEvaluation
MSC:w NCLEX:wSafewandwEffectivewCarewEnvironment:wManagementwofwCare
4. Thewnursewiswassignedwtowawpatientwwhowiswnewlywdiagnosedwwithwtypew1wdiabetesw
mellitus.wWhichwstatementwbestwillustrateswanwoutcomewcriterionwforwthiswpatient?
a. Thewpatientwwillwfollowwinstructions.
b. Thewpatientwwillwnotwexperiencewcomplications.
c. Thewpatientwwillwadherewtowthewnewwinsulinwtreatmentwregimen.
d. Thewpatientwwillwdemonstratewcorrectwbloodwglucosewtestingwtechnique.
ANS:w D
“Demonstratingwcorrectwbloodwglucosewtestingwtechnique”wiswawspecificwandwmeasurable
woutcomewcriterion.w“Followingwinstructions”wandw“notwexperiencingwcomplications”ware
wnotwspecificwcriteria.w“Adheringwtownewwregimen”wwouldwbewdifficultwtowmeasure.
DIF: CognitivewLevel:wApplyingw(Application)
TOP:w NursingwProcess:wPlanning
MSC:w NCLEX:wSafewandwEffectivewCarewEnvironment:wManagementwofwCare
5. Whichwactivitywbestwreflectswthewimplementationwphasewofwthewnursingwprocesswforwthe
wpatientwwhowiswnewlywdiagnosedwwithwhypertension?
a. Providingweducationwonwkeepingwawjournalwofwbloodwpressurewreadings
b. Settingwgoalswandwoutcomewcriteriawwithwthewpatient’swinput
c. Recordingwawdrugwhistorywregardingwover-the-counterwmedicationswusedwatwhome
d. Formulatingwhumanwneedswstatementswregardingwinsufficientwknowledgewrelate
dwtowthewnewwtreatmentwregimen
ANS:w A
Educationwiswanwinterventionwthatwoccurswduringwthewimplementationwphase.wSettingwg
oalswandwoutcomeswreflectswthewplanningwphase.wRecordingwawdrugwhistorywreflectswthe
wassessmentwphase.wFormulatingwhumanwneedswstatementswreflectswanalysiswofwdatawas
wpartwofwplanning.
DIF:
CognitivewLevel:wApplyingw(Applicatio
n)wTOP:w NursingwProcess:wImplementation
MSC:w NCLEX:wSafewandwEffectivewCarewEnvironment:wManagementwofwCare
6. Thewmedicationworderwreads,w“Givewondansetronw(Zofran)w4wmg,w30wminuteswbeforewb
eginningwchemotherapywtowpreventwnausea.”wThewnursewnoteswthatwthewroutewiswmissing
wfromwtheworder.wWhatwiswthewnurse’swbestwaction?
a. Givewthewmedicationwintravenouslywbecausewthewpatientwmightwvomit.
b. Givewthewmedicationworallywbecausewthewtabletswarewavailablewinw4-mgwdoses.
c. Contactwthewprescriberwtowclarifywthewroutewofwthewmedicationwordered.
d. Holdwthewmedicationwuntilwthewprescriberwreturnswtowmakewrounds.
ANS:w C
Awcompletewmedicationworderwincludeswthewroutewofwadministration.wIfwawmedicationwo
rderwdoeswnotwincludewthewroute,wthewnursewmustwaskwthewprescriberwtowclarifywit.wThe
wintravenouswandworalwrouteswarewnotwinterchangeable.wHoldingwthewmedicationwuntilwth
ewprescriberwreturnswwouldwmeanwthatwthewpatientwwouldwnotwreceivewawneededwmedica
tion.
DIF: CognitivewLevel:wApplyingw(Application)
Chapterw1w- 4
wThewNursingwProcesswandwDrugwTherapy
